NO305595B1 - Fenoksyfenyl-cyklopentyl-hydroksyurinstoffer, farmas°ytisk preparat og anvendelse derav - Google Patents

Fenoksyfenyl-cyklopentyl-hydroksyurinstoffer, farmas°ytisk preparat og anvendelse derav

Info

Publication number
NO305595B1
NO305595B1 NO960631A NO960631A NO305595B1 NO 305595 B1 NO305595 B1 NO 305595B1 NO 960631 A NO960631 A NO 960631A NO 960631 A NO960631 A NO 960631A NO 305595 B1 NO305595 B1 NO 305595B1
Authority
NO
Norway
Prior art keywords
pct
date
phenoxyphenylcyclopentyl
hydroxyureas
above compounds
Prior art date
Application number
NO960631A
Other languages
English (en)
Norwegian (no)
Other versions
NO960631D0 (no
NO960631L (no
Inventor
Akiyoshi Kawai
Rodney W Stevens
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO960631D0 publication Critical patent/NO960631D0/no
Publication of NO960631L publication Critical patent/NO960631L/no
Publication of NO305595B1 publication Critical patent/NO305595B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO960631A 1993-08-19 1996-02-16 Fenoksyfenyl-cyklopentyl-hydroksyurinstoffer, farmas°ytisk preparat og anvendelse derav NO305595B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20545393 1993-08-19
PCT/JP1994/001349 WO1995005360A1 (en) 1993-08-19 1994-08-15 Phenoxyphenyl cyclopentenyl hydroxyureas

Publications (3)

Publication Number Publication Date
NO960631D0 NO960631D0 (no) 1996-02-16
NO960631L NO960631L (no) 1996-02-16
NO305595B1 true NO305595B1 (no) 1999-06-28

Family

ID=16507136

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960631A NO305595B1 (no) 1993-08-19 1996-02-16 Fenoksyfenyl-cyklopentyl-hydroksyurinstoffer, farmas°ytisk preparat og anvendelse derav

Country Status (27)

Country Link
US (1) US5792882A (da)
EP (1) EP0720598B1 (da)
JP (1) JP2794343B2 (da)
KR (1) KR0170623B1 (da)
CN (1) CN1077568C (da)
AT (1) ATE171939T1 (da)
AU (1) AU674776B2 (da)
BR (1) BR9407314A (da)
CA (1) CA2169066C (da)
CO (1) CO4230229A1 (da)
CZ (1) CZ288358B6 (da)
DE (1) DE69413831T2 (da)
DK (1) DK0720598T3 (da)
EC (1) ECSP941144A (da)
EG (1) EG20530A (da)
ES (1) ES2121218T3 (da)
FI (1) FI114466B (da)
IL (1) IL110628A (da)
MY (1) MY111140A (da)
NO (1) NO305595B1 (da)
NZ (1) NZ269849A (da)
PE (1) PE57194A1 (da)
PL (1) PL176223B1 (da)
RU (1) RU2125987C1 (da)
TW (2) TW448144B (da)
WO (1) WO1995005360A1 (da)
ZA (1) ZA946253B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE9600184A (et) * 1994-06-27 1997-06-16 Cytomed, Inc. Kardiovaskulaar-, inflammatoor- ja immuunhaiguste raviühendid ja -meetodid
EP0790981B1 (en) * 1994-11-10 1999-09-08 Pfizer Inc. Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors
WO1996016054A1 (en) * 1994-11-18 1996-05-30 Pfizer Pharmaceuticals Inc. Cycloalkenyl-n-hydroxyureas
EP1741424B1 (en) 1997-08-11 2018-10-03 Pfizer Products Inc. Solid pharmaceutical dispersions with enhanced bioavailabilty
US6121323A (en) * 1997-12-03 2000-09-19 3M Innovative Properties Company Bishydroxyureas
DE602005025934D1 (de) * 2004-12-02 2011-02-24 Amorepacific Corp Die produktion von tnf-alpha inhibierenden 2-cyclopenten-1-onoximderivate
KR101494488B1 (ko) * 2007-12-03 2015-02-24 (주)아모레퍼시픽 2-사이클로펜텐-1-온 옥심 유도체를 유효성분으로 포함하는 지방대사질환 예방 및 치료용 약학 조성물
KR101739994B1 (ko) 2009-04-03 2017-05-25 에프. 호프만-라 로슈 아게 프로판-１-술폰산 ｛３-［５-（４-클로로-페닐）-１Ｈ-피롤로［２，３-ｂ］피리딘-３-카르보닐］-２，４-디플루오로-페닐｝-아미드 조성물 및 그의 용도
US8512464B2 (en) * 2009-12-02 2013-08-20 3M Innovative Properties Company Functionalized zirconia nanoparticles and high index films made therefrom

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222168A (en) * 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
US5026729A (en) * 1987-02-10 1991-06-25 Abbott Laboratories Lipoxygenase inhibiting compounds
CA2009201A1 (en) * 1989-02-03 1990-08-03 William Paul Jackson Anti-inflammatory aryl derivatives
US5037853A (en) * 1989-12-28 1991-08-06 Abbott Laboratories Cyclopropyl derivative lipoxygenase inhibitors
US5120752A (en) * 1989-12-28 1992-06-09 Abbott Laboratories Cyclopropyl derivative lipoxygenase inhibitors
GB9025514D0 (en) * 1990-11-23 1991-01-09 Wellcome Found Anti-inflammatory compounds
JP3007138B2 (ja) * 1990-11-27 2000-02-07 ファイザー製薬株式会社 新規なヒドロキサム酸とｎ―ヒドロキシ尿素誘導体およびそれらの組成物
JPH06256285A (ja) * 1990-12-11 1994-09-13 Pfizer Pharmaceut Co Ltd ヒドロキサム酸誘導体およびその用途
US5130485A (en) * 1991-04-23 1992-07-14 Eli Lilly And Company N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents
US5149097A (en) * 1991-05-01 1992-09-22 Tonello John H Crossword puzzle aid
JPH05163229A (ja) * 1991-12-13 1993-06-29 Pfizer Pharmaceut Co Ltd 新規なシクロプロピル誘導体
JPH05294921A (ja) * 1992-04-17 1993-11-09 Pfizer Pharmaceut Co Ltd 新規なフェニル置換シクロアルキル尿素誘導体および組成物

Also Published As

Publication number Publication date
WO1995005360A1 (en) 1995-02-23
CO4230229A1 (es) 1995-10-19
CZ288358B6 (en) 2001-05-16
FI943799A0 (fi) 1994-08-18
KR0170623B1 (ko) 1999-03-30
US5792882A (en) 1998-08-11
ZA946253B (en) 1996-02-19
RU2125987C1 (ru) 1999-02-10
AU674776B2 (en) 1997-01-09
EP0720598A1 (en) 1996-07-10
ATE171939T1 (de) 1998-10-15
FI943799L (fi) 1995-02-20
DE69413831T2 (de) 1999-02-25
ES2121218T3 (es) 1998-11-16
JPH08511031A (ja) 1996-11-19
NO960631D0 (no) 1996-02-16
NZ269849A (en) 1997-10-24
MY111140A (en) 1999-08-30
EP0720598B1 (en) 1998-10-07
CA2169066C (en) 1999-06-22
JP2794343B2 (ja) 1998-09-03
CZ48396A3 (en) 1996-07-17
CN1129440A (zh) 1996-08-21
IL110628A (en) 1998-12-27
TW448144B (en) 2001-08-01
DE69413831D1 (de) 1998-11-12
FI114466B (fi) 2004-10-29
ECSP941144A (es) 1995-02-27
CN1077568C (zh) 2002-01-09
AU7350994A (en) 1995-03-14
PL313037A1 (en) 1996-05-27
PE57194A1 (es) 1995-02-07
NO960631L (no) 1996-02-16
CA2169066A1 (en) 1995-02-23
EG20530A (en) 1999-07-31
DK0720598T3 (da) 1999-06-21
TW418089B (en) 2001-01-11
KR960703845A (ko) 1996-08-31
BR9407314A (pt) 1996-04-16
IL110628A0 (en) 1994-11-11
PL176223B1 (pl) 1999-05-31

Similar Documents

Publication Publication Date Title
FI943948A0 (fi) Heterosykliset hiilihappojohdannaiset
DK0731794T3 (da) 1,4,5-Triphenyl-pyrazolforbindelser til behandling af inflammation og inflammationsbeslægtede lidelser
ATE206123T1 (de) Phenylxanthin-derivate
DK0532527T3 (da) 3-amino-2-arylquinuclidiner, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse
FI990418A0 (fi) Typpeä sisältävien heterosyklisten yhdisteiden fluorialkoksibentsyyliaminojohdannaiset
FI932229A0 (fi) Azabicykliska bryggderivat
DE69505542D1 (de) 3-benzoylbenzofuran-derivate als thyroidhormonantagonisten
NO306345B1 (no) Piperidin-derivater med PAF antagonist-aktivitet, anvendelse derav og farmasöytisk blanding
ATE196293T1 (de) Triazole enthaltende antifungizide mittel
DK0782567T3 (da) Isothiourinstofderivater og fremgangsmåder til deres fremstilling
DK0759026T3 (da) Amidderivater og deres terapeutiske anvendelse
NO305595B1 (no) Fenoksyfenyl-cyklopentyl-hydroksyurinstoffer, farmas°ytisk preparat og anvendelse derav
NO306400B1 (no) N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat
ATE144497T1 (de) N-substituierte 3-azabicyclo(3.2.0&gt;heptan- derivate als neuroleptika
FI974444A0 (fi) N-hydroksiureayhdisteitä anti-inflammatorisina aineina
DK0581904T3 (da) Fremgangsmåde til inhibering af fibrose
NO307517B1 (no) 4-(6-fluor-1,2-benzisoksazolyl)-1-piperidinyl-propoksy-kromen- 4-on-derivater, farmasøytisk preparat inneholdende slike derivater, og deres anvendelse
NO305799B1 (no) Nye kinolinderivater, farmas°ytiske preparater inneholdende slike derivater, deres anvendelse samt mellomprodukter
NO306463B1 (no) Nye substituerte oksazolidiner, farmasöytisk preparat inneholdene slike forbindelser og deres anvendelse

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees